StockMacro
Menu

Becton, Dickinson and

$212.78 +44% in 6 monthsMarket cap $58.0B

BDX on XNYS, Health Care, Becton, Dickinson and Co., job postings

Measures activity, not value. Not investment advice.

Shares rose 44% in six months while latest quarter revenue fell 9.5% and profit fell 41% over 12 months.

  • BadApplications to hire foreign specialists down 34%, to 110 from 167

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Jun 2026

Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
72,000
Website
bd.com
Listed
NYSE, US
Last results
5 Nov 2026
Next results
expected around 8 Feb 2027 (an estimate: a year ago it reported on 9 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Jun 2026: revenue $5.0B, net income $377.0M.
Quarter to 31 Dec 2021: revenue $5.0B, net income $677.0MQuarter to 31 Dec 2021: revenue $5.0B, net income $677.0MQuarter to 31 Mar 2022: revenue $5.0B, net income $454.0MQuarter to 31 Mar 2022: revenue $5.0B, net income $454.0MQuarter to 30 Jun 2022: revenue $4.6B, net income $360.0MQuarter to 30 Jun 2022: revenue $4.6B, net income $360.0MQuarter to 30 Sep 2022: revenue –, net income $288.0MQuarter to 31 Dec 2022: revenue $4.6B, net income $509.0MQuarter to 31 Dec 2022: revenue $4.6B, net income $509.0MQuarter to 31 Mar 2023: revenue $4.8B, net income $460.0MQuarter to 31 Mar 2023: revenue $4.8B, net income $460.0MQuarter to 30 Jun 2023: revenue $4.9B, net income $407.0MQuarter to 30 Jun 2023: revenue $4.9B, net income $407.0MQuarter to 30 Sep 2023: revenue –, net income $108.0MQuarter to 31 Dec 2023: revenue $4.7B, net income $281.0MQuarter to 31 Dec 2023: revenue $4.7B, net income $281.0MQuarter to 31 Mar 2024: revenue $5.0B, net income $537.0MQuarter to 31 Mar 2024: revenue $5.0B, net income $537.0MQuarter to 30 Jun 2024: revenue $5.0B, net income $487.0MQuarter to 30 Jun 2024: revenue $5.0B, net income $487.0MQuarter to 30 Sep 2024: revenue $5.4B, net income $400.0MQuarter to 30 Sep 2024: revenue $5.4B, net income $400.0MQuarter to 31 Dec 2024: revenue $5.2B, net income $303.0MQuarter to 31 Dec 2024: revenue $5.2B, net income $303.0MQuarter to 31 Mar 2025: revenue $5.3B, net income $308.0MQuarter to 31 Mar 2025: revenue $5.3B, net income $308.0MQuarter to 30 Jun 2025: revenue $5.5B, net income $574.0MQuarter to 30 Jun 2025: revenue $5.5B, net income $574.0MQuarter to 30 Sep 2025: revenue $5.9B, net income $493.0MQuarter to 30 Sep 2025: revenue $5.9B, net income $493.0MQuarter to 31 Dec 2025: revenue $5.3B, net income $382.0MQuarter to 31 Dec 2025: revenue $5.3B, net income $382.0MQuarter to 31 Mar 2026: revenue $4.7B, net income -$311.0MQuarter to 31 Mar 2026: revenue $4.7B, net income -$311.0MQuarter to 30 Jun 2026: revenue $5.0B, net income $377.0MQuarter to 30 Jun 2026: revenue $5.0B, net income $377.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $5.9B30 Jun 2026
See the numbers
Quarter toRevenueNet income
30 Jun 2026$5.0B$377.0M
31 Mar 2026$4.7B-$311.0M
31 Dec 2025$5.3B$382.0M
30 Sep 2025$5.9B$493.0M
30 Jun 2025$5.5B$574.0M
31 Mar 2025$5.3B$308.0M
31 Dec 2024$5.2B$303.0M
30 Sep 2024$5.4B$400.0M
30 Jun 2024$5.0B$487.0M
31 Mar 2024$5.0B$537.0M
31 Dec 2023$4.7B$281.0M
30 Sep 2023–$108.0M
30 Jun 2023$4.9B$407.0M
31 Mar 2023$4.8B$460.0M
31 Dec 2022$4.6B$509.0M
30 Sep 2022–$288.0M
30 Jun 2022$4.6B$360.0M
31 Mar 2022$5.0B$454.0M
31 Dec 2021$5.0B$677.0M
Fundamentals, 12 months to 30 Jun 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $20.8B $19.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +5.2% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $941.0M $1.6B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $3.32 $5.48
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 46.4% 44.5% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 9.6% 11.1% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 4.5% 8.0% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 3.8% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – $2.5B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $708.0M $735.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $16.8B $19.3B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $16.1B $18.6B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.69 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 61.6 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.8 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 3.6 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.4 2.8
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 2.0% 1.4%

Latest = 12 months to 30 Jun 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Becton, Dickinson andBDX (this company) $58.0B61.62.8+5.2%4.5%
Boston ScientificBSX $60.8B17.42.9+8.9%16.6%
3MMMM $91.8B26.03.6+1.7%14.0%
ResMedRMD $33.1B20.85.8+9.0%27.8%
MedlineMDLN $32.5B36.61.1–2.9%
DexComDXCM $29.6B29.95.8+13%19.4%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$689K

bought $0, sold $689K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+5.3%

1,482 13F filers vs 1,408

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

94%

254.9M shares held by 13F filers (30 Sep 2026) of 272.4M outstanding (30 Jun 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.0%

8.1M shares sold short (30 Oct 2026) of 272.4M outstanding (30 Jun 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.2

8.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-9.0%

8.9M shares sold short in the report before, 8.1M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

41%

41% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 52%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

539

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-34%

110 vs 167 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-9.5%

$5.0B vs $5.5B (quarter ended 30 Jun 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$16K

the 12 months before: $0

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$3.3M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

30

30 articles in the last 7 days; its usual week has 5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.0×

30 articles in the last 7 days; its usual week has 5.

Unusual now sharp changes in the last 90 days, compared with its own past

  • New lobbying issue

Price $212.78 on 20 Nov 2026, +12% over 12 months (12-month range $140.71 to $218.03)

  • Sharp change
  • 8-K and other filings
  • WARN layoff notice
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $3.4M in the last 12 months (the 12 months before: -$3.2M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 110 published in the last 12 months, -34% on the 12 months before.
Revenue per quarter. Revenue $5.0B in the latest quarter, -9.5% on a year earlier.
Capital spending per quarter. Capital spending $108.0M in the latest quarter, +2.9% on a year earlier.
Institutional holders (13F filers). 1,482 13F filers reported holding it in the latest 13F quarter, +5.1% on a year earlier.
Federal obligations. Federal obligations: $16K published in the last 12 months (none in the 12 months before).
Lobbying spend. Lobbying spend: $3.3M published in the last 12 months, +8.5% on the 12 months before.
Workers in WARN layoff notices. Workers in WARN layoff notices: 0 published in the last 12 months, -100% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
20 Oct 2026Sharp changeLobbying on a new issue: lobbying on a new issue: IMM (2026-09-30)
22 Sep 2026Lobbying filingnew lobbying registration (BROWNSTEIN HYATT FARBER SCHRECK, LLP)
22 Jul 20268-K and other filingsDirector or officer change
22 Jul 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Apr 2026Sharp changeShort interest spike: short interest spike, 9.5M vs usual 4.4M (2026-03-31); 2.5x the same period a year earlier
9 Apr 20268-K and other filingsDirector or officer change
6 Apr 2026Lobbying filinglobbying engagement terminated (SQUIRE PATTON BOGGS)
31 Mar 2026Sharp changeShort interest spike: short interest spike, 11.5M vs usual 4.2M (2026-03-13); 4.0x the same period a year earlier
17 Mar 2026Sharp changeShort interest spike: short interest spike, 13.8M vs usual 4.1M (2026-02-27); 4.7x the same period a year earlier
3 Mar 2026Sharp changeShort interest spike: short interest spike, 14.6M vs usual 4.0M (2026-02-13); 3.9x the same period a year earlier
9 Feb 20268-K and other filingsDirector or officer change
30 Jan 20268-K and other filingsDirector or officer change
20 Jan 2026Sharp changeLobbying spend jump: lobbying spend jump, 1.5M vs usual 554K (2025-12-31); 3.1x the same period a year earlier
20 Jan 2026Sharp changeLobbying on a new issue: lobbying on a new issue: TAR (2025-12-31)
17 Nov 20258-K and other filingsDirector or officer change
13 Nov 2025Lobbying filingnew lobbying registration (DCI GROUP, L.L.C.)
1 Nov 2025WARN layoff noticeBecton Dickinson and Company, 86 workers, Franklin Lakes, NJ
1 Nov 2025Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 86)
15 Oct 20258-K and other filingsDirector or officer change
15 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Jul 2025Lobbying filinglobbying engagement terminated (KING & SPALDING LLP)
29 Apr 2025Sharp changeShort interest spike: short interest spike, 4.1M vs usual 2.3M (2025-04-15); 1.8x the same period a year earlier
27 Mar 20258-K and other filingsDirector or officer change
20 Mar 2025Lobbying filingnew lobbying registration (BGR GOVERNMENT AFFAIRS)
19 Feb 2025Lobbying filingnew lobbying registration (SQUIRE PATTON BOGGS)
28 Jan 2025Sharp changeShort interest spike: short interest spike, 3.5M vs usual 2.2M (2025-01-15); 1.5x the same period a year earlier
14 Jan 2025Sharp changeShort interest spike: short interest spike, 3.7M vs usual 2.2M (2024-12-31); 1.8x the same period a year earlier
10 Jan 20258-K and other filingsDirector or officer change
10 Jan 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Aug 20248-K and other filingsDirector or officer change
30 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Feb 20248-K and other filingsDirector or officer change
27 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Nov 20238-K and other filingsDirector or officer change
27 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Nov 2023Lobbying filingnew lobbying registration (TRADEWINS, LLC)
18 Oct 2023WARN layoff noticeBecton, Dickinson and Company, 72 workers, Vernon Hills, IL
1 Oct 2023WARN layoff noticeBecton, Dickinson, and Company, 57 workers, Lakes, NJ
1 Oct 2023Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 57)
24 Jul 20238-K and other filingsDirector or officer change
24 Jul 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jan 20238-K and other filingsDirector or officer change
20 Jan 2023Lobbying filinglobbying engagement terminated (BAKER & HOSTETLER LLP)
6 Jan 20238-K and other filingsDirector or officer change
6 Jan 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
25 Aug 20228-K and other filingsDirector or officer change
25 Aug 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Apr 20228-K and other filingsDirector or officer change
31 Mar 20228-K and other filingsDirector or officer change
1 Mar 20228-K and other filingsDirector or officer change
1 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Nov 2021Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 465.0M vs usual 234.0M (2021-09-30); 2.2x the same period a year earlier
Insider net buying (open market)
Month from 1 Dec 2021: -$910K published
Month from 1 Feb 2022: -$2.0M published
Month from 1 Mar 2022: -$3.9M published
Month from 1 May 2022: -$122K published
Month from 1 Jun 2022: -$115K published
Month from 1 Aug 2022: -$7.4M published
Month from 1 Feb 2023: -$353K published
Month from 1 Aug 2023: -$1.4M published
Month from 1 Sep 2023: -$126K published
Month from 1 Nov 2023: -$514K published
Month from 1 Dec 2023: -$288K published
Month from 1 Mar 2024: -$67K published
Month from 1 May 2024: -$2.0M published
Month from 1 Jun 2024: -$72K published
Month from 1 Dec 2024: -$2.3M published
Month from 1 Jan 2025: -$635K published
Month from 1 Feb 2025: $191K published
Month from 1 Mar 2025: -$542K published
Month from 1 Apr 2025: -$94K published
Month from 1 Jun 2025: -$200K published
Month from 1 Jul 2025: -$214K published
Month from 1 Aug 2025: $829K published
Month from 1 Sep 2025: -$182K published
Month from 1 Oct 2025: -$11K published
Month from 1 Nov 2025: -$38K published
Month from 1 Dec 2025: -$152K published
Month from 1 Jan 2026: -$349K published
Month from 1 Feb 2026: -$188K published
Month from 1 Mar 2026: -$12K published
Month from 1 Apr 2026: -$11K published
Month from 1 May 2026: -$11K published
Month from 1 Jun 2026: -$743K published
Month from 1 Jul 2026: -$12K published
Month from 1 Aug 2026: -$1.2M published
Month from 1 Sep 2026: -$14K published
Month from 1 Oct 2026: -$15K published
Month from 1 Nov 2026: -$629K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 40 published
Quarter from 1 Apr 2022: 31 published
Quarter from 1 Jul 2022: 74 published
Quarter from 1 Oct 2022: 24 published
Quarter from 1 Jan 2023: 19 published
Quarter from 1 Apr 2023: 18 published
Quarter from 1 Jul 2023: 67 published
Quarter from 1 Oct 2023: 24 published
Quarter from 1 Jan 2024: 28 published
Quarter from 1 Apr 2024: 20 published
Quarter from 1 Jul 2024: 50 published
Quarter from 1 Oct 2024: 36 published
Quarter from 1 Jan 2025: 22 published
Quarter from 1 Apr 2025: 29 published
Quarter from 1 Jul 2025: 89 published
Quarter from 1 Oct 2025: 27 published
Quarter from 1 Jan 2026: 20 published
Quarter from 1 Apr 2026: 12 published
Quarter from 1 Jul 2026: 51 published
Quarter from 1 Oct 2026: 27 published
Revenue per quarter
Quarter ended 30 Sep 2021: $5.1B, +7.3% on a year earlier; public on 25 Nov 2021
Quarter ended 31 Dec 2021: $5.0B, -6.0% on a year earlier; public on 4 Feb 2022
Quarter ended 31 Mar 2022: $5.0B, +2.1% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $4.6B, -5.1% on a year earlier; public on 5 Aug 2022
Quarter ended 31 Dec 2022: $4.6B, -8.2% on a year earlier; public on 3 Feb 2023
Quarter ended 31 Mar 2023: $4.8B, -3.8% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $4.9B, +5.1% on a year earlier; public on 4 Aug 2023
Quarter ended 31 Dec 2023: $4.7B, +2.6% on a year earlier; public on 2 Feb 2024
Quarter ended 31 Mar 2024: $5.0B, +4.6% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $5.0B, +2.3% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $5.4B; public on 28 Nov 2024
Quarter ended 31 Dec 2024: $5.2B, +9.8% on a year earlier; public on 7 Feb 2025
Quarter ended 31 Mar 2025: $5.3B, +4.5% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $5.5B, +10% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $5.9B, +8.4% on a year earlier; public on 26 Nov 2025
Quarter ended 31 Dec 2025: $5.3B, +1.6% on a year earlier; public on 10 Feb 2026
Quarter ended 31 Mar 2026: $4.7B, -11% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $5.0B, -9.5% on a year earlier; public on 7 Aug 2026
Capital spending per quarter
Quarter ended 30 Sep 2021: $465.0M, +118% on a year earlier; public on 25 Nov 2021
Quarter ended 31 Dec 2021: $188.0M, -24% on a year earlier; public on 4 Feb 2022
Quarter ended 31 Mar 2022: $227.0M, -10% on a year earlier; public on 6 May 2022
Quarter ended 31 Dec 2022: $208.0M, +11% on a year earlier; public on 3 Feb 2023
Quarter ended 30 Jun 2023: $191.0M; public on 4 Aug 2023
Quarter ended 31 Dec 2023: $116.0M, -44% on a year earlier; public on 2 Feb 2024
Quarter ended 31 Mar 2024: $134.0M; public on 3 May 2024
Quarter ended 30 Jun 2024: $179.0M, -6.3% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $296.0M; public on 28 Nov 2024
Quarter ended 31 Dec 2024: $105.0M, -9.5% on a year earlier; public on 7 Feb 2025
Quarter ended 31 Mar 2025: $129.0M, -3.7% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $174.0M, -2.8% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $352.0M, +19% on a year earlier; public on 26 Nov 2025
Quarter ended 31 Dec 2025: $108.0M, +2.9% on a year earlier; public on 10 Feb 2026
Institutional holders (13F filers)
31 Dec 2021 report: 1,386; public on 14 Feb 2022
31 Mar 2022 report: 1,461; public on 16 May 2022
30 Jun 2022 report: 1,425; public on 15 Aug 2022
30 Sep 2022 report: 1,368; public on 14 Nov 2022
31 Dec 2022 report: 1,415; public on 14 Feb 2023
31 Mar 2023 report: 1,413; public on 15 May 2023
30 Jun 2023 report: 1,441; public on 14 Aug 2023
30 Sep 2023 report: 1,424; public on 14 Nov 2023
31 Dec 2023 report: 1,467; public on 14 Feb 2024
31 Mar 2024 report: 1,511; public on 15 May 2024
30 Jun 2024 report: 1,506; public on 14 Aug 2024
30 Sep 2024 report: 1,480; public on 14 Nov 2024
31 Dec 2024 report: 1,539; public on 14 Feb 2025
31 Mar 2025 report: 1,528; public on 15 May 2025
30 Jun 2025 report: 1,450; public on 14 Aug 2025
30 Sep 2025 report: 1,410; public on 14 Nov 2025
31 Dec 2025 report: 1,476; public on 17 Feb 2026
31 Mar 2026 report: 1,427; public on 15 May 2026
30 Jun 2026 report: 1,408; public on 14 Aug 2026
30 Sep 2026 report: 1,482; public on 16 Nov 2026
Federal obligations
Month from 1 Apr 2026: $16K published
Lobbying spend
Quarter from 1 Jan 2022: $750K published
Quarter from 1 Apr 2022: $650K published
Quarter from 1 Jul 2022: $500K published
Quarter from 1 Oct 2022: $440K published
Quarter from 1 Jan 2023: $480K published
Quarter from 1 Apr 2023: $570K published
Quarter from 1 Jul 2023: $310K published
Quarter from 1 Oct 2023: $310K published
Quarter from 1 Jan 2024: $720K published
Quarter from 1 Apr 2024: $872K published
Quarter from 1 Jul 2024: $427K published
Quarter from 1 Oct 2024: $400K published
Quarter from 1 Jan 2025: $485K published
Quarter from 1 Apr 2025: $1.4M published
Quarter from 1 Jul 2025: $557K published
Quarter from 1 Oct 2025: $550K published
Quarter from 1 Jan 2026: $1.5M published
Quarter from 1 Apr 2026: $780K published
Quarter from 1 Jul 2026: $622K published
Quarter from 1 Oct 2026: $390K published
Workers in WARN layoff notices
Month from 1 Oct 2023: 129 published
Month from 1 Nov 2025: 86 published

What is unusual now

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 4 sales, $689K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
9 Nov 2026Thomas E Polen JrChairman, CEO and PresidentSellplanned in advance (10b5-1); after exercising options2,993$210.00$629KForm 4
27 Oct 2026Michael FeldEVP, Chief Revenue OfficerSellplanned in advance (10b5-1)76$198.13$15KForm 4
29 Sep 2026Michael FeldEVP, Chief Revenue OfficerSellplanned in advance (10b5-1)76$183.70$14KForm 4
27 Aug 2026Michael FeldEVP, Chief Revenue OfficerSellplanned in advance (10b5-1)165$188.49$31KForm 4
14 Aug 2026Thomas E Polen JrChairman, CEO and PresidentSellplanned in advance (10b5-1); after exercising options4,152$185.00$768KForm 4
12 Aug 2026Roland GoetteEVP and President, EMEASell2,438$180.84$441KForm 4
28 Jul 2026Michael FeldEVP, Chief Revenue OfficerSellplanned in advance (10b5-1)75$157.13$12KForm 4
26 Jun 2026Michael FeldEVP, Chief Revenue OfficerSellplanned in advance (10b5-1)75$152.80$11KForm 4

1,482 institutions reported shares at the end of Q3 2026, 94% of the shares outstanding; 156 opened a position, 96 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.23.6M8.67%$4.2B-975K-4.0%
Vanguard Capital Management LLC17.8M6.54%$3.2B-168K-0.9%
State Street Corp15.2M5.58%$2.7B+209K+1.4%
Vanguard Portfolio Management LLC14.7M5.40%$2.6B-276K-1.8%
First Eagle Investment Management, LLC13.9M5.10%$2.5B-13.7M-50%
Invesco Ltd.8.9M3.26%$1.6B-27K-0.3%
Geode Capital Management, LLC8.1M2.97%$1.4B-53K-0.6%
Massachusetts Financial Services Co7.8M2.85%$2.4B-891K-10%
Franklin Templeton Inc7.7M2.81%$1.6B+643K+9.2%
Greenhaven Associates Inc5.9M2.17%$1.1B+223K+3.9%

Federal contracts

All 1 federal contracts

No new award in 12 months; the latest was signed 10 Sep 2009. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
10 Sep 2009Department of State$1.2MPURCHASE OF LABORATORY EQUIPMENT (CELL COUNT SYSTEMS AND FLOW CYTOMETERS) ON BEHALF OF CDC ETHIOPIA.USAspending

Company events

All 59 company events

In 12 months: 4 director or officer changes, 2 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
22 Jul 2026Director or officer change8-K
20 May 2026Signed a major agreementSame filing: took on new debt8-K
9 Apr 2026Director or officer change8-K
9 Feb 2026Director or officer change; Signed a major agreement8-K
30 Jan 2026Director or officer changeSame filing: shareholder vote results8-K
17 Nov 2025Director or officer change8-K
15 Oct 2025Director or officer change8-K
17 Sep 2025Signed a major agreementSame filing: took on new debt8-K

539 open postings; careers site tracked since 21 Nov 2026. Most in Manufacturing & production 10%, Test, quality & reliability 7%, Sales & business development 6%, Marketing & communications 5%.

PostedJobLocation
21 Nov 2026or earlierTech, Mold Maker-2nd ShiftUSA PR - Anasco
21 Nov 2026or earlierLead Operations Manufacturing MechanicManufacturing & productionUSA SC - Sumter
21 Nov 2026or earlierDirector, Systems Engineering– Pharmacy AutomationUSA NC - Durham - Roche Drive
21 Nov 2026or earlierPrincipal Algorithms EngineerUSA CA - Irvine Laguna Canyon
21 Nov 2026or earlierSr. Design Quality EngineerTest, quality & reliabilityUSA NJ - Franklin Lakes
21 Nov 2026or earlierDirector Procurement, UCC Business UnitSupply chain & procurementUSA GA - Covington BMD
21 Nov 2026or earlierDiagnostic Solutions Account Executive Portland, OregonSales & business developmentUSA - Oregon - Portland
21 Nov 2026or earlierStaff Software EngineerSoftware engineeringUSA CA - Milpitas 155

Reported lobbying spend: $390K in Q3 2026, $622K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
15 Sep 2026NewBrownstein Hyatt Farber Schreck, LLPfor Becton, Dickinson And CompanyIssues related to medical technology regulation. Issues related to medical device reimbursement. Medical device supply chain and international trade issues.Health issues, Medicare/Medicaid, TradeFiling
31 Mar 2026EndedSquire Patton Boggsfor Becton, Dickinson And CompanyNot statedFiling
1 Oct 2025NewDci Group, L.L.C.for Becton, Dickinson And CompanyProvide strategic counsel and advocate on issues related to medical device regulation, supply chains, and tradeTARFiling
30 Jun 2025EndedKing & Spalding LLPfor Becton, Dickinson And CompanyIssues affecting manufacturer and direct supplier of medical products and diagnostics, including access, reimbursement, and supply chain considerations.Health issuesFiling
3 Feb 2025NewBGR Government Affairsfor Becton, Dickinson And CompanyProvide strategic counsel and advocate on issues related to medical device regulation, supply chains and tradeTARFiling
8 Jan 2025NewSquire Patton Boggsfor Becton, Dickinson And CompanyGeneral issues impacting medical technology.Health issues, TradeFiling
15 Jun 2023NewTradewins, LLCfor Hogan Lovells US LLP (On Behalf Of Becton Dickinson & Co.)medical device supply chain issues; import competition; international tradeTradeFiling
31 Dec 2022EndedBaker & Hostetler LLPfor Becton, Dickinson And CompanyRegulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid.Health issuesFiling

Layoff notices

All 4 layoff notices

No notice in 12 months; the latest is dated 1 Oct 2025. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Oct 2025Becton Dickinson and CompanyFranklin Lakes, NJ8631 Jan 2025Notice
17 Oct 2023Becton, Dickinson and CompanyLake County, IL7217 Dec 2023closureNotice
1 Sep 2023Becton, Dickinson, and CompanyLakes, NJ5722 Sep 2023Notice
1 Jun 2014CareFusion Resources, LLCSan Diego, NJ3908 Aug 2014Notice

The 5 newest of 314 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 20 Oct 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['IMM']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4288726
  2. 22 Sep 2026Lobbying record

    BECTON, DICKINSON AND COMPANY: new lobbying registration (BROWNSTEIN HYATT FARBER SCHRECK, LLP) (dated 15 Sep 2026)

  3. 22 Jul 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 22 Jul 2026Filings record

    Director or officer change

  5. 11 Apr 2026Short interest and volume change

    had 9.5M shares sold short in the 31 Mar 2026 report, 2.5× the same report last year.

    Same report last year: 3.8M; its normal report is 4.4M.

    See the evidence
    This period
    9.5M (the 31 Mar 2026 report)
    Normal report (median of 24 earlier)
    4.4M
    Typical spread (median absolute deviation)
    919K
    How far from its usual level
    +3.7
    Same report last year
    3.8M
    History used
    3,014 days
    2025-03-31: 3.8M2025-04-15: 4.1M2025-04-30: 3.6M2025-05-15: 3.3M2025-05-30: 3.2M2025-06-13: 3.2M2025-06-30: 3.9M2025-07-15: 4.7M2025-07-31: 5.5M2025-08-15: 5.2M2025-08-29: 4.6M2025-09-15: 4.3M2025-09-30: 3.8M2025-10-15: 3.3M2025-10-31: 3.1M2025-11-14: 4.2M2025-11-28: 4.8M2025-12-15: 4.8M2025-12-31: 6.0M2026-01-15: 6.1M2026-01-30: 6.7M2026-02-13: 14.6M2026-02-27: 13.8M2026-03-13: 11.5M2026-03-31: 9.5M
    the 31 Mar 2026 report24 earlier reportsnormal: 4.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 9 Apr 2026Filings record

    Director or officer change

  7. 6 Apr 2026Lobbying record

    BECTON, DICKINSON AND COMPANY: lobbying engagement terminated (SQUIRE PATTON BOGGS) (dated 31 Mar 2026)

  8. 25 Mar 2026Short interest and volume change

    had 11.5M shares sold short in the 13 Mar 2026 report, 4.0× the same report last year.

    Same report last year: 2.9M; its normal report is 4.2M.

    See the evidence
    This period
    11.5M (the 13 Mar 2026 report)
    Normal report (median of 24 earlier)
    4.2M
    Typical spread (median absolute deviation)
    948K
    How far from its usual level
    +5.2
    Same report last year
    2.9M
    History used
    2,996 days
    2025-03-14: 2.9M2025-03-31: 3.8M2025-04-15: 4.1M2025-04-30: 3.6M2025-05-15: 3.3M2025-05-30: 3.2M2025-06-13: 3.2M2025-06-30: 3.9M2025-07-15: 4.7M2025-07-31: 5.5M2025-08-15: 5.2M2025-08-29: 4.6M2025-09-15: 4.3M2025-09-30: 3.8M2025-10-15: 3.3M2025-10-31: 3.1M2025-11-14: 4.2M2025-11-28: 4.8M2025-12-15: 4.8M2025-12-31: 6.0M2026-01-15: 6.1M2026-01-30: 6.7M2026-02-13: 14.6M2026-02-27: 13.8M2026-03-13: 11.5M
    the 13 Mar 2026 report24 earlier reportsnormal: 4.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 11 Mar 2026Short interest and volume change

    had 13.8M shares sold short in the 27 Feb 2026 report, 4.7× the same report last year.

    Same report last year: 2.9M; its normal report is 4.1M.

    See the evidence
    This period
    13.8M (the 27 Feb 2026 report)
    Normal report (median of 24 earlier)
    4.1M
    Typical spread (median absolute deviation)
    855K
    How far from its usual level
    +7.6
    Same report last year
    2.9M
    History used
    2,982 days
    2025-02-28: 2.9M2025-03-14: 2.9M2025-03-31: 3.8M2025-04-15: 4.1M2025-04-30: 3.6M2025-05-15: 3.3M2025-05-30: 3.2M2025-06-13: 3.2M2025-06-30: 3.9M2025-07-15: 4.7M2025-07-31: 5.5M2025-08-15: 5.2M2025-08-29: 4.6M2025-09-15: 4.3M2025-09-30: 3.8M2025-10-15: 3.3M2025-10-31: 3.1M2025-11-14: 4.2M2025-11-28: 4.8M2025-12-15: 4.8M2025-12-31: 6.0M2026-01-15: 6.1M2026-01-30: 6.7M2026-02-13: 14.6M2026-02-27: 13.8M
    the 27 Feb 2026 report24 earlier reportsnormal: 4.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 26 Feb 2026Short interest and volume change

    had 14.6M shares sold short in the 13 Feb 2026 report, 3.9× the same report last year.

    Same report last year: 3.7M; its normal report is 4.0M.

    See the evidence
    This period
    14.6M (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    4.0M
    Typical spread (median absolute deviation)
    750K
    How far from its usual level
    +9.5
    Same report last year
    3.7M
    History used
    2,968 days
    2025-02-14: 3.7M2025-02-28: 2.9M2025-03-14: 2.9M2025-03-31: 3.8M2025-04-15: 4.1M2025-04-30: 3.6M2025-05-15: 3.3M2025-05-30: 3.2M2025-06-13: 3.2M2025-06-30: 3.9M2025-07-15: 4.7M2025-07-31: 5.5M2025-08-15: 5.2M2025-08-29: 4.6M2025-09-15: 4.3M2025-09-30: 3.8M2025-10-15: 3.3M2025-10-31: 3.1M2025-11-14: 4.2M2025-11-28: 4.8M2025-12-15: 4.8M2025-12-31: 6.0M2026-01-15: 6.1M2026-01-30: 6.7M2026-02-13: 14.6M
    the 13 Feb 2026 report24 earlier reportsnormal: 4.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 9 Feb 2026Filings record

    Director or officer change

  12. 30 Jan 2026Filings record

    Director or officer change

  13. 20 Jan 2026Lobbying change

    reported $1.5M of lobbying spend for the quarter ended 31 Dec 2025, 3.1× the same quarter last year.

    Same quarter last year: $485K; its normal quarter is $554K.

    See the evidence
    This period
    $1.5M (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    $554K
    Typical spread (median absolute deviation)
    $140K
    How far from its usual level
    +4.5
    Same quarter last year
    $485K
    History used
    6,301 days
    2023-12-31: $720K2024-03-31: $872K2024-06-30: $427K2024-09-30: $400K2024-12-31: $485K2025-03-31: $1.4M2025-06-30: $557K2025-09-30: $550K2025-12-31: $1.5M
    the quarter ended 31 Dec 20258 earlier quartersnormal: $554K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  14. 20 Jan 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['TAR']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4688017
  15. 17 Nov 2025Filings record

    Director or officer change

  16. 13 Nov 2025Lobbying record

    BECTON, DICKINSON AND COMPANY: new lobbying registration (DCI GROUP, L.L.C.) (dated 1 Oct 2025)

  17. 1 Nov 2025Layoff notices change

    filed a WARN layoff notice covering 86 workers within 30 days (Franklin Lakes, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    86
    Window
    2 Oct 2025 to 1 Nov 2025

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  18. 1 Nov 2025Layoff notices record

    WARN notice: Becton Dickinson and Company, 86 workers, Franklin Lakes, NJ (dated 1 Oct 2025)

  19. 15 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 15 Oct 2025Filings record

    Director or officer change

  21. 12 Aug 2025Insiders record

    HAYES GREGORY (director) bought 5,250 shares of BDX ($1.0M) (dated 11 Aug 2025)

  22. 21 Jul 2025Lobbying record

    BECTON, DICKINSON AND COMPANY: lobbying engagement terminated (KING & SPALDING LLP) (dated 30 Jun 2025)

  23. 13 May 2025Institutional holdings record

    GQG Partners LLC opened a $690.0M position (2025Q1 13F)

  24. 26 Apr 2025Short interest and volume change

    had 4.1M shares sold short in the 15 Apr 2025 report, 1.8× the same report last year.

    Same report last year: 2.3M; its normal report is 2.3M.

    See the evidence
    This period
    4.1M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    339K
    How far from its usual level
    +3.5
    Same report last year
    2.3M
    History used
    2,664 days
    2024-04-15: 2.3M2024-04-30: 2.2M2024-05-15: 2.0M2024-05-31: 2.2M2024-06-14: 2.0M2024-06-28: 2.3M2024-07-15: 2.2M2024-07-31: 2.0M2024-08-15: 1.5M2024-08-30: 2.0M2024-09-13: 2.7M2024-09-30: 2.5M2024-10-15: 2.4M2024-10-31: 2.0M2024-11-15: 2.1M2024-11-29: 1.9M2024-12-13: 2.6M2024-12-31: 3.7M2025-01-15: 3.5M2025-01-31: 2.7M2025-02-14: 3.7M2025-02-28: 2.9M2025-03-14: 2.9M2025-03-31: 3.8M2025-04-15: 4.1M
    the 15 Apr 2025 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 27 Mar 2025Filings record

    Director or officer change

  26. 20 Mar 2025Lobbying record

    BECTON, DICKINSON AND COMPANY: new lobbying registration (BGR GOVERNMENT AFFAIRS) (dated 3 Feb 2025)

  27. 19 Feb 2025Lobbying record

    BECTON, DICKINSON AND COMPANY: new lobbying registration (SQUIRE PATTON BOGGS) (dated 8 Jan 2025)

  28. 11 Feb 2025Insiders record

    Henderson Jeffrey William (director) bought 1,500 shares of BDX ($350,430) (dated 10 Feb 2025)

  29. 28 Jan 2025Short interest and volume change

    had 3.5M shares sold short in the 15 Jan 2025 report, 1.5× the same report last year.

    Same report last year: 2.3M; its normal report is 2.2M.

    See the evidence
    This period
    3.5M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    2.2M
    Typical spread (median absolute deviation)
    231K
    How far from its usual level
    +3.5
    Same report last year
    2.3M
    History used
    2,574 days
    2024-01-12: 2.3M2024-01-31: 2.5M2024-02-15: 2.5M2024-02-29: 2.1M2024-03-15: 2.8M2024-03-28: 2.9M2024-04-15: 2.3M2024-04-30: 2.2M2024-05-15: 2.0M2024-05-31: 2.2M2024-06-14: 2.0M2024-06-28: 2.3M2024-07-15: 2.2M2024-07-31: 2.0M2024-08-15: 1.5M2024-08-30: 2.0M2024-09-13: 2.7M2024-09-30: 2.5M2024-10-15: 2.4M2024-10-31: 2.0M2024-11-15: 2.1M2024-11-29: 1.9M2024-12-13: 2.6M2024-12-31: 3.7M2025-01-15: 3.5M
    the 15 Jan 2025 report24 earlier reportsnormal: 2.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 14 Jan 2025Short interest and volume change

    had 3.7M shares sold short in the 31 Dec 2024 report, 1.8× the same report last year.

    Same report last year: 2.1M; its normal report is 2.2M.

    See the evidence
    This period
    3.7M (the 31 Dec 2024 report)
    Normal report (median of 24 earlier)
    2.2M
    Typical spread (median absolute deviation)
    224K
    How far from its usual level
    +4.6
    Same report last year
    2.1M
    History used
    2,559 days
    2023-12-29: 2.1M2024-01-12: 2.3M2024-01-31: 2.5M2024-02-15: 2.5M2024-02-29: 2.1M2024-03-15: 2.8M2024-03-28: 2.9M2024-04-15: 2.3M2024-04-30: 2.2M2024-05-15: 2.0M2024-05-31: 2.2M2024-06-14: 2.0M2024-06-28: 2.3M2024-07-15: 2.2M2024-07-31: 2.0M2024-08-15: 1.5M2024-08-30: 2.0M2024-09-13: 2.7M2024-09-30: 2.5M2024-10-15: 2.4M2024-10-31: 2.0M2024-11-15: 2.1M2024-11-29: 1.9M2024-12-13: 2.6M2024-12-31: 3.7M
    the 31 Dec 2024 report24 earlier reportsnormal: 2.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 10 Jan 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 10 Jan 2025Filings record

    Director or officer change

  33. 30 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 30 Aug 2024Filings record

    Director or officer change

  35. 27 Feb 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 27 Feb 2024Filings record

    Director or officer change

  37. 27 Nov 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 27 Nov 2023Filings record

    Director or officer change

  39. 9 Nov 2023Lobbying record

    HOGAN LOVELLS US LLP (ON BEHALF OF BECTON DICKINSON & CO.): new lobbying registration (TRADEWINS, LLC) (dated 15 Jun 2023)

  40. 18 Oct 2023Layoff notices record

    WARN notice (closure): Becton, Dickinson and Company, 72 workers, Vernon Hills, IL (dated 17 Oct 2023)

Showing the newest 40 of 131 entries; narrow the window or the kind of data to see older ones.

Not listed: 320 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000010795
Ticker
BDX
Domain
bd.com
Employer name
augusta life sciences us opco i, Becton, Dickinson and Company, Becton, Dickinson and Company (BD), CareFusion Resources, LLC (3 unverified)
Hq location
NJ|FRANKLIN LAKES|07417 (1 unverified)
Lobbying client
becton dickinson, hogan lovells us llp on behalf of becton dickinson
Name
Accuri Cytometers, Inc, Adaptec Medical Devices LLC, Alverix, Inc, Angiomed GmbH & Co. Medizintechnik KG and 322 more
Uei
CXGGWD8229L6, HPD3MN5DSDB6, M6CMG9BJMYW4, MM8DPDMTKF24 and 2 more
Wikidata
Q813780
Wikipedia
BD (company)
  • DOL H-1B labor condition applications and PERM certifications1711 data points1 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)40 records, 279 data points30 Dec 1950 to 30 Sep 2026
  • SEC Form 13F institutional holdings8 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)196 records29 Jan 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1138 data points30 Sep 2006 to 30 Jun 2026
  • SEC Form 4 insider transactions166 records, 540 data points9 May 2016 to 9 Nov 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards1 record, 105 data points30 Oct 2007 to 14 Apr 2026
  • WARN layoff notices (state labor agencies)4 records, 12 data points26 May 2014 to 1 Oct 2025
  • Wikipedia pageviews2420 data points7 Apr 2020 to 21 Nov 2026